BioPharmSignal logoBioPharmSignal

Biotech News

Cross Country Appoints Darrick Sogabe as Chief Product Officer, Advancing the Company’s Growing Technology Portfolio

Cross Country Healthcare (CCRN)Cross Country HealthcareCompany update

Architect of Intellify® to lead next phase of product strategy, platform innovation, and enterprise growth BOCA RATON, Fla. --(BUSINESS WIRE)--Apr. 23, 2026-- Cross Country Healthcare, Inc. (Nasdaq: CCRN), a technology-driven healthcare workforce solutions company, today announced the appointment

Related news

CCRNCross Country Healthcare2026-04-21 11:30 EST

Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy

CCRNCross Country Healthcare2026-05-05 11:00 EST

Cross Country Healthcare and Florida Atlantic University’s Christine E. Lynn College of Nursing Release Purpose Under Pressure: The State of Nursing in 2026

View all latest news

Cross Country Healthcare

Cross Country Healthcare is a healthcare staffing and workforce solutions company serving hospitals, clinics, and other providers. Its business is tied to labor supply and staffing demand in healthcare.

Recent company news

CCRNCross Country Healthcare2026-05-14 11:30 EST

Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution

CCRNCross Country Healthcare2026-05-07 20:15 EST

Cross Country Healthcare Announces First Quarter 2026 Financial Results

CCRNCross Country Healthcare2026-05-06 21:32 EST

Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million

CCRNCross Country Healthcare2026-05-05 11:00 EST

Cross Country Healthcare and Florida Atlantic University’s Christine E. Lynn College of Nursing Release Purpose Under Pressure: The State of Nursing in 2026

CCRNCross Country Healthcare2026-04-28 11:30 EST

Cross Country Healthcare Marks 40 Years, Accelerates Next Generation of Workforce Intelligence and Orchestration

Stock data

Close
13.25 USD
Market cap
405.9M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States